Acrivon Therapeutics Inc. Common Stock (ACRV) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Acrivon Therapeutics Inc....

NASDAQ: ACRV · Real-Time Price · USD
1.91
0.05 (2.69%)
At close: Oct 03, 2025, 3:59 PM
1.91
-0.04%
After-hours: Oct 03, 2025, 06:51 PM EDT

Acrivon Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
39.82M 36.02M 29.52M 99.6M
Short-Term Investments
139.66M 91.44M 98.23M n/a
Long-Term Investments
5.09M 414K 41.88M 388K
Other Long-Term Assets
1.84M 251K 388K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.15M 2.23M 4.34M n/a
Total Current Assets
181.63M 129.69M 132.09M 100.41M
Property-Plant & Equipment
8.03M 7.91M 6.86M 5.79M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
14.96M 8.57M 49.13M 6.18M
Total Assets
196.59M 138.26M 181.23M 106.59M
Account Payables
758K 5.05M 904K 964K
Deferred Revenue
n/a n/a 69K 66K
Short-Term Debt
1.06M 877K 726K 664K
Other Current Liabilities
5.46M 2.64M 1.94M -111K
Total Current Liabilities
17.21M 13.3M 6.52M 2.91M
Long-Term Debt
n/a n/a n/a 122.52M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
2.59M 3.77M 4.24M 127.48M
Total Liabilities
19.8M 17.07M 10.75M 130.4M
Total Debt
3.65M 4.64M 4.96M 5.63M
Book Value
176.79M 121.19M 170.47M -23.81M
Book Value Per Share
0.52 5.49 7.78 -1.14
Common Stock
31K 23K 22K 2K
Retained Earnings
-196.98M -116.42M -56.03M -24.86M
Comprehensive Income
447K -83K -95K n/a
Shareholders Equity
176.79M 121.19M 170.47M -23.81M
Total Investments
144.75M 91.86M 140.11M 388K